FIELD: pharmacology.
SUBSTANCE: invention relates to a synergistic pharmaceutical composition with anti-tuberculosis activity, containing cycloserine and a zinc-containing compound as active principle.
EFFECT: composition of the invention is characterized by increased anti-tuberculosis activity, pharmacokinetics and reduced toxicity.
17 cl, 6 ex, 12 tbl, 2 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 | 
 | RU2478389C2 | 
| COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 | 
 | RU2354378C1 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 | 
 | RU2468802C2 | 
| ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 | 
 | RU2423977C1 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 | 
 | RU2413517C1 | 
| COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |  | RU2247560C1 | 
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 | 
 | RU2430724C2 | 
| ANTITUBERCULOUS AGENT | 2003 |  | RU2247559C1 | 
| COMBINED THERAPY OF TUBERCULOSIS | 2009 | 
 | RU2484819C2 | 
| ANTITUBERCULOSIS PHARMACEUTICAL COMPOSITION CONTAINING THIOACETAZONE | 2015 | 
 | RU2627611C2 | 
Authors
Dates
2017-05-30—Published
2016-03-01—Filed